PCA
TDOC icon

Pallas Capital Advisors’s Teladoc Health TDOC Stock Holding History

Pallas Capital Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$195K Buy
23,038
+9,299
+68% +$61.9K 0.01% 912
2026
Q1 		$74.9K Buy
+13,739
New +$77.1K ﹤0.01% 811

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Pallas Capital Advisors's TDOC Position: Q2 2026 in Review

Pallas Capital Advisors increased its Teladoc Health (TDOC) stake by 68% in Q2 2026, buying an estimated $61.9K and bringing the position to 23,038 shares worth $195K. The position accounts for 0.01% of the portfolio, ranked #912.

Pallas Capital Advisors first reported a position in TDOC in Q1 2026 and has held it in 2 quarters since. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Pallas Capital Advisors held 23,038 shares of Teladoc Health worth $195K as of Q2 2026.
  • Pallas Capital Advisors bought 9,299 Teladoc Health shares in Q2 2026, an estimated $61.9K.
  • Teladoc Health made up 0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #912 holding.
  • Pallas Capital Advisors first reported a position in Teladoc Health in Q1 2026 and has held it in 2 quarters since.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.